France· FR:66446220
VYVGART 1 000 mg, solution injectable en seringue préremplie
A medicinal product containing efgartigimod alfa, registered in France by ARGENX (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EFGARTIGIMOD ALFA
- Manufacturer
- ARGENX (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009303152861 seringue(s) préremplie(s) en verre de 5 mlEUR 12.58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplieargenx Switzerland SA
- CzechiaVYVGARTargenx BV, Gent
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
- FinlandVyvgartArgenx
- SwedenVyvgart 1000 mg Injektionsvätska, lösningArgenx
- PolandVyvgartargenx BV
- BelgiumVyvgart 1000 mgArgenx
- United KingdomVyvgart 1000mg/5.6ml solution for injection vialsArgenx UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ab95c80-d3e7-40a5-8f6c-a8b87797fce3 GET /v1/drugs/1ab95c80-d3e7-40a5-8f6c-a8b87797fce3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66446220",
"date_amm": "2025-06-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/22/1674",
"substance": "EFGARTIGIMOD ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.